Meta Pharmacy Services recalls sterile eye drops due to lack of sterility assurance
Meta Pharmacy Services recalls 5mL phenylephrine 2.5% + tropicamide 1% eye drops (NDC 99999-0106-99) because they lack sterility assurance. This compounded drug is for hospital/office use only and not for resale.
Recall notice
Lack of Sterility Assurance
Contact the company
What happened, in plain English
Meta Pharmacy Services is recalling phenylephrine 2.5% + tropicamide 1% eye drops (5 mL bottles) because they were compounded without proper sterility assurance. This poses a risk of infection since the product is intended for medical use only. Read more at govinfonow.com/recall/42125-meta-pharmacy-services-recalls-sterile-eye-drops-due-to-lack.
Source Summary by GovInfoNow · govinfonow.com/recall/42125-meta-pharmacy-services-recalls-sterile-eye-drops-due-to-lack · Updated October 8, 2026 · FDA enforcement record: FDA #D-0227-2017
Cite this page
“Meta Pharmacy Services recalls sterile eye drops due to lack of sterility assurance.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42125-meta-pharmacy-services-recalls-sterile-eye-drops-due-to-lack. Based on FDA recall #D-0227-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0227-2017%22&limit=1).
Why it’s dangerous
The eye drops were compounded without proper sterility assurance, meaning they could be contaminated with bacteria. This is dangerous because the product is intended for direct medical use and not for resale, increasing the risk of infection if used improperly.
Who’s affected
People who received these eye drops from Meta Pharmacy Services for medical use. Hospital and office settings that used these drops are at higher risk.
How to tell if you have this one
Check for 5 mL bottles labeled 'Phenylephrine 2.5% + Tropicamide 1%'. The NDC code is 99999-0106-99. These drops were sold for hospital/office use only and not for resale.
- Brand
Meta Pharmacy Services- Category
Drug
What to do — step by step
Check for Contamination
If you have these eye drops, check for signs of contamination such as discoloration or unusual odor.
How this recall unfolded
Recall timeline
FDA terminated this recall 33 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0227-2017 (December 15, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0227-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.